Halozyme Therapeutics (HALO) Tax Rate (2016 - 2026)

Halozyme Therapeutics (HALO) has 11 years of Tax Rate data on file, last reported at 16.79% in Q1 2026.

• Tax Rate for Q1 2026 came in at 16.79%, down 110.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 30.7% (up 1093.0% YoY), and the FY2025 annual result was 32.13%, up 1184.0% from the prior year.
• Tax Rate advanced to 16.79% in Q1 2026 per HALO's latest filing, from 40.4% in the prior quarter.
• Over five years, Tax Rate peaked at 24.41% in Q2 2022 and troughed at 40.4% in Q4 2025.
• A 5-year average of 16.01% and a median of 19.42% in 2025 frame the typical range for Tax Rate.
• The sharpest annual moves came in 2022 and 2025: Tax Rate surged 20865 bps in 2022, then slumped 6352 bps in 2025.
• A 5-year view of Tax Rate shows it stood at 18.49% in 2022, then declined by 16 bps to 15.6% in 2023, then soared by 48 bps to 23.12% in 2024, then slumped by 275 bps to 40.4% in 2025, then surged by 142 bps to 16.79% in 2026.
• Business Quant data shows HALO's Tax Rate at 16.79% in Q1 2026, 40.4% in Q4 2025, and 19.96% in Q3 2025.